Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis

BACKGROUND: The American College of Cardiology and American Heart Association (ACC/AHA) issued new cholesterol treatment guidelines in 2013. Two of the groups designated for primary prevention were analyzed: patients with a low-density lipoprotein cholesterol (LDL-C) level ≥ 190 mg per dL and diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xue, Fox, D. Steven, Chu, Michelle, Dougherty, J. Samantha, McCombs, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397869/
https://www.ncbi.nlm.nih.gov/pubmed/30362921
http://dx.doi.org/10.18553/jmcp.2018.24.11.1078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397869/
https://www.ncbi.nlm.nih.gov/pubmed/30362921
http://dx.doi.org/10.18553/jmcp.2018.24.11.1078

Ejemplares similares